Inventories (Details) (USD $)	Dec. 31, 2012	Sep. 30, 2012	Dec. 31, 2011
Inventories [Abstract]
Raw materials	$ 3,184,000		$ 1,797,000
Work in progress	904,000		84,000
Finished goods	6,336,000		9,260,000
Inventory, net	10,424,000		11,141,000	[1]
Inventory held at distributors	2,300,000		2,300,000
Restatement of Inventory		$ 1,300,000	$ 2,300,000

[1] Accounts receivable decreased $3.8 million and inventory increased $2.3 million related to the Company changing from the “sell-in” method to the “sell-through” method of revenue recognition for certain Pfizer products sold by the Company.